Search results for: 'prevention disease'

This study presents an overview of the Asia-Pacific infectious disease point-of-care testing (POCT) market with an emphasis on some of the key trends and growth opportunities that are shaping the market. The study highlights some of the emerging business models supporting the development and adoption of innovative diagnostic tests. The Asia-Pacif...

The drug approvals of Yescarta (axicabtagene ciloleucel), Luxturna (Voretigene neparvovec) and Kymriah (Tisagenlecleucel) have turned a leaf in the pharmaceutical chapter of gene therapy development. Currently, genetic disorders do not have satisfactory treatment outcomes. This is in part due to the inability of small molecule drugs and enzyme repl...

This research addresses the Data Leakage Prevention and Data Loss Protection (DLP/ILP) Market. Specifically included in this research are companies that provide DLP/ILP products and solutions that reside at the network's perimeter and its endpoints such as workstations and laptop. This research will be limited to actual products and solutions and ...

This report will analyze the World Intrusion Detection System (IDS) and Intrusion Prevention System (IPS) markets, using 2003 as a base year. This report will be segmented by network intrusion detection/prevention systems (NIDS) and host-based intrusion detection/prevention systems (HIDS). Throughout the text, distinctions between the technologie...

This research service will analyze the World Intrusion Detection System (IDS) and Intrusion Prevention System (IPS) markets, using 2006 as a base year. This research will be segmented by network intrusion detection/prevention systems (NIDS) and host-based intrusion detection/prevention systems (HIDS). Throughout the text, distinctions between the...

01 Mar 2024  |  North America  |  Market Research

Global Orphan Drug Growth Opportunities

Reduced Exclusivity and Increased Competition will Drive Demand for More Efficient R&D and Digital Solutions

Infographics

×

In this study, Frost & Sullivan s Transformational Health team provides critical insights into the global orphan drug (OD) industry and highlights growth opportunities, revenue, regulatory changes, and technology trends influencing growth. Approximately 5% of rare diseases (RDs) have received US FDA approval for a drug, while up to 15% of RDs have ...

03 Mar 2022  |  North America  |  Frost Radar

Frost Radar™: US eCommerce Fraud Prevention, 2022

A Benchmarking System to Spark Companies to Action—Innovation that Fuels New Deal Flow and Growth Pipelines

Infographics

×

The US eCommerce market is on a strong growth trajectory. Revenue grew 20% in 2021 to approximately $850 billion. Many of the purchasing trends that emerged at the beginning of the pandemic have become permanent as consumers embraced the ease and convenience of home delivery and curbside or in-store pickups. Frost & Sullivan’s research indicates th...

The US eCommerce fraud prevention market is on a growth trajectory: eCommerce sales are expected to generate more than $700 billion in the United States by 2023. However, the online environment has emerged as the preferred channel for fraudulent transactions, given that card-not-present payments present various opportunities. By analyzing various d...

This research service evaluates the global autoimmune disease diagnostics markets from 2009 to 2018. The market includes two segments, which include analysis for the markets for localized autoimmune disease diagnostic tests and for the systemic autoimmune disease diagnostic tests. This research service offers a discussion of the key market drivers ...